Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (253)
- Medicine safety (170)
- Prescription medicines (154)
- COVID-19 (144)
- Regulatory compliance (135)
- COVID-19 vaccines (88)
- Legislation (84)
- Therapeutic goods regulation (75)
- Listed medicines (61)
- Non-prescription medicines (56)
- Safety (51)
- Medical devices safety (49)
- Complementary medicines (44)
- Manufacturing (40)
- Vaping hub (40)
- Over the counter (OTC) medicines (35)
- Australian Register of Therapeutic Goods (ARTG) (30)
- Labelling and packaging (30)
- Assessed listed medicines (26)
- Compliance and enforcement hub (25)
- Alert/Advisory (24)
- Scheduling (national classification system) (24)
- Medicinal cannabis hub (22)
- Import and export (21)
- Shortages (13)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (11)
- Weight loss products (11)
- Biological medicines (6)
- Advisory bodies and committees (5)
- Cosmetics (4)
- Registered complementary medicines (4)
- Unique Device Identification (UDI) hub (4)
- Blood and blood components (3)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Advanced therapies (1)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Search
1129 result(s) found, displaying 1 to 25
-
Media releasesThe TGA has facilitated the seizure of millions of counterfeit and illegal therapeutic goods as part of a global initiative targeting illegal trade.
-
NewsInformation on the completion of automatic extensions for Good Manufacturing Practice (GMP) clearances and next steps.
-
Media releasesThe TGA suggests extra safety measures for some sunscreen ingredients but advises Australians to keep using sunscreen. Public consultation will determine safe levels.
-
NewsFollowing a number of stakeholder queries, the TGA is providing an updated statement on the PFAS ban. The original statement was published on 27 June 2025.
-
NewsIn 2025, the Therapeutic Goods (Exempt Monographs) Amendment Determination was introduced under the Therapeutic Goods Act 1989. This amendment updates the 2021 determination to exempt specific labelling requirements in certain pharmacopoeial monographs.
-
NewsAn update about expected increases in the number of medical device incident reports reported to the TGA
-
NewsWe've updated the Listed Medicine Compliance Reports database with the results of compliance reviews covering 51 listed medicines
-
NewsTemporary risk-based strategies to expedite the reduction of the GMP Clearance Compliance Verification (CV) backlog commences today.
-
Media releasesAustralians who rely on medical devices will benefit from new measures introduced by the Australian Government to enhance the identification and management of device-related safety concerns.
-
NewsOur second online study is open now.
-
NewsMedical devices, including components in the device, primary packaging, instructions for use, and spare parts, will not be affected by the PFAS ban.
-
Media releasesWe are aware that recent media reports have stated that the TGA estimates that more than 10 million vapes are sold nationally every month on the black market. These reports are incorrect.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Media releasesThe TGA has accepted a court-enforceable undertaking from The Aussie Gelatin Company Pty Ltd (Aussie Gelatin) in relation to the alleged unlawful manufacture, supply and advertising of therapeutic goods.
-
Compliance undertakingsWe have accepted a court-enforceable undertaking from The Aussie Gelatin Company Pty Ltd (Aussie Gelatin) in relation to the alleged unlawful manufacture, supply and advertising of therapeutic goods.
-
Media releasesWe have issued an infringement notice of $18,780 to Victorian-based company, Nourishmeorganics Pty Ltd, for the alleged unlawful supply of a therapeutic good not entered in the ARTG.
-
Safety updatesInformation about the indications for the individual products and how to avoid administration errors.
-
NoticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2025, which commenced on 20 June 2025.
-
Atlus, Mamamia and News Life Media face court for alleged unlawful advertising of medicinal cannabis
Media releasesWe have commenced proceedings in the Federal Court of Australia against Atlus and its sole director, Mamamia, News Life and Straight Up for advertising medicinal cannabis in alleged contravention of the Therapeutic Goods Act 1989. -
NewsLearn about the strengthened standards for all therapeutic vaping goods for smoking cessation and nicotine dependence.
-
NewsThis statement is an update to provide technical clarification regarding information on laboratory testing and release of information by the TGA. The original statement was published on 12 June 2025.
-
NewsWe are aware of a CHOICE report where a number of sunscreens were found to not meet their claimed Sun Protection Factor (SPF) ratings.
-
Media releasesThe Therapeutic Goods Administration has commenced proceedings in the Federal Court of Australia against Philips Electronics Australia Limited (PEAL) for the alleged unlawful supply of medical devices that did not meet Australian safety and performance requirements.
-
Safety updatesNew warnings added of risks during anaesthesia or deep sedation.
-
NewsFollowing a public consultation process , the TGA has adopted the following 19 international scientific guidelines.
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- …
- Next page Next ›
- Last page Last »